<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08851</article-id><article-id pub-id-type="doi">10.7554/eLife.08851</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Maternal LSD1/KDM1A is an essential regulator of chromatin and transcription landscapes during zygotic genome activation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-34773"><name><surname>Ancelin</surname><given-names>Katia</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34774"><name><surname>Syx</surname><given-names>Laurène</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34775"><name><surname>Borensztein</surname><given-names>Maud</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45724"><name><surname>Ranisavljevic</surname><given-names>Noémie</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45725"><name><surname>Vassilev</surname><given-names>Ivaylo</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34776"><name><surname>Briseño-Roa</surname><given-names>Luis</given-names></name><aff><institution>High Fidelity Biology</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34785"><name><surname>Liu</surname><given-names>Tao</given-names></name><aff><institution>Annoroad Gene Technology Co., Ltd</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34786"><name><surname>Metzger</surname><given-names>Eric</given-names></name><aff><institution>Urologische Klinik und  Zentrale Klinische Forschung</institution>, <addr-line><named-content content-type="city">Freiburg</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34779"><name><surname>Servant</surname><given-names>Nicolas</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34780"><name><surname>Barillot</surname><given-names>Emmanuel</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34781"><name><surname>Chen</surname><given-names>Chong-Jian</given-names></name><aff><institution>Annoroad Gene Technology Co., Ltd</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34782"><name><surname>Schüle</surname><given-names>Roland</given-names></name><aff><institution>Urologische Klinik und  Zentrale Klinische Forschung</institution>, <addr-line><named-content content-type="city">Freiburg</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6256"><name><surname>Heard</surname><given-names>Edith</given-names></name><aff><institution>Institut Curie</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country><email>Edith.Heard@curie.fr</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1083"><name><surname>Ferguson-Smith</surname><given-names>Anne C</given-names></name><role>Reviewing editor</role><aff><institution>University of Cambridge</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>02</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e08851</elocation-id><supplementary-material><ext-link xlink:href="elife-08851-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>21</day><month>05</month><year>2015</year></date><date date-type="accepted"><day>25</day><month>01</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Ancelin et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Ancelin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Upon fertilization, the highly specialised sperm and oocyte genomes are remodelled to confer totipotency. The mechanisms of the dramatic reprogramming events that occur have remained unknown, and presumed roles of histone modifying enzymes are just starting to be elucidated. Here, we explore the function of the oocyte-inherited pool of a histone H3K4 and K9 demethylase, LSD1/KDM1A during early mouse development. KDM1A deficiency results in developmental arrest by the two-cell stage, accompanied by dramatic and stepwise alterations in H3K9 and H3K4 methylation patterns. At the transcriptional level, the switch of the maternal-to-zygotic transition fails to be induced properly and LINE-1 retrotransposons are not properly silenced. We propose that KDM1A plays critical roles in establishing the correct epigenetic landscape of the zygote upon fertilization, in preserving genome integrity and in initiating new patterns of genome expression that drive early mouse development.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice used were handled with care and according to approved institutional animal care and use committee of the Institut Curie (CEEA-IC) protocols(C 75-05-18). The work has also been conducted under the approval from the French Ministry of Higher Education and Research for the use of Genetically Modified Organisms (agreement number 5549CA-I).</p></fn></fn-group></back></article>